Aran Singanayagam

Has grant

Imperial College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Understanding the role of the respiratory tract microbiota in immunity to bacterial infection in COPD

Open Date: 2019-01-17

Close Date: 2020-01-17

Grant: Close

The effect of inhaled corticosteroids on viral and bacterial infection in chronic obstructive pulmonary disease.

Open Date: 2011-09-30

Close Date: 2014-09-29

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

James R Edgar

UNITED KINGDOM

View details

Mehmet Kesimer

Professor

University of North Carolina

UNITED STATES

View details

Matthias Marczynski

Ludwig-Maximilians-Universität München

GERMANY

View details

Eteri Regis

Imperial College London

UNITED KINGDOM

View details

Nathan Bartlett

Professor

Newcastle University

AUSTRALIA

View details

Claire Hogg

Professor in Practice, paediatric Respiratory medicine

UNITED KINGDOM

View details

Evgeni Mekov

medical university of sofia

BULGARIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aran Singanayagam

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Stepping Up the Personalized Approach in COPD with Machine Learning

Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease

A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae

Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19

Ultrastructural insight into SARS-CoV-2 entry and budding in human airway epithelium

Our evolving view of neutrophils in defining the pathology of chronic lung disease

Gateway to the lungs: Viral entry receptors and susceptibility to COVID‐19

Beclomethasone Has Lesser Suppressive Effects on Inflammation and Antibacterial Immunity Than Fluticasone or Budesonide in Experimental Infection Models.

Repurposing Existing Drugs for the Treatment of COVID-19.

Repurposing Existing Drugs for the Treatment of COVID-19

Collaborators (7)

James R Edgar

Mehmet Kesimer

Matthias Marczynski

Eteri Regis

Nathan Bartlett

Claire Hogg

Evgeni Mekov

Make your next move.